Her primary areas of study are Immunology, IL-2 receptor, Interleukin 10, FOXP3 and Cell biology. As part of her studies on Immunology, Silvia Gregori often connects relevant subjects like Nod. Within one scientific family, Silvia Gregori focuses on topics pertaining to Natural killer T cell under IL-2 receptor, and may sometimes address concerns connected to Interleukin 3 and Effector.
Silvia Gregori is investigating Interleukin 10 as part of her Immune system and Cytokine and Interleukin 10 study. Her FOXP3 research includes themes of Cell therapy and Transplantation. Her Cell biology study integrates concerns from other disciplines, such as Suppressor and T cell.
Silvia Gregori focuses on Immunology, Immune system, Interleukin 10, Cell biology and T cell. Her research investigates the connection with Immunology and areas like Transplantation which intersect with concerns in Islet. Silvia Gregori interconnects HLA-G, Myeloid, Cell therapy and Antigen in the investigation of issues within Immune system.
Silvia Gregori combines subjects such as Immunosuppression and In vivo with her study of Interleukin 10. Her studies in T cell integrate themes in fields like Molecular biology, Cellular differentiation and NOD mice. As a part of the same scientific study, Silvia Gregori usually deals with the Antigen-presenting cell, concentrating on Natural killer T cell and frequently concerns with IL-2 receptor.
Her scientific interests lie mostly in Immune system, Immunology, Cancer research, Antigen and HLA-G. Her work carried out in the field of Immune system brings together such families of science as Viral vector, Cell therapy and Cell biology. The various areas that Silvia Gregori examines in her Cell therapy study include Adoptive cell transfer and Interleukin 10.
Immunology and Regulation of gene expression are commonly linked in her work. Her Cancer research study combines topics from a wide range of disciplines, such as Genetic enhancement and Immunotherapy. As part of one scientific family, she deals mainly with the area of Antigen, narrowing it down to issues related to the FOXP3, and often Function, Islet and Insulitis.
Her main research concerns Immune system, Immunology, Transplantation, Cell biology and Antigen. She studied Immune system and Effector that intersect with Function, Inflammation, Tissue homeostasis, Tolerance induction and Autoimmunity. Her study in Immunology focuses on Myeloid in particular.
Her Transplantation research incorporates themes from Translational medicine, Antigen-presenting cell, Immune tolerance, Cell therapy and Computational biology. Her work deals with themes such as In vitro, HEK 293 cells, Gene, Exon and Mutagenesis, which intersect with Cell biology. Silvia Gregori has researched Antigen in several fields, including T cell and FOXP3.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.
Maria Grazia Roncarolo;Silvia Gregori;Manuela Battaglia;Rosa Bacchetta.
Immunological Reviews (2006)
Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance
Silvia Gregori;Mara Casorati;Susana Amuchastegui;Simona Smiroldo.
Journal of Immunology (2001)
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
Nicola Gagliani;Chiara F. Magnani;Samuel Huber;Monica E. Gianolini;Monica E. Gianolini.
Nature Medicine (2013)
A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice
Silvia Gregori;Nadia Giarratana;Simona Smiroldo;Milan Uskokovic.
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells.
Megan K. Levings;Silvia Gregori;Eleonora Tresoldi;Sabrina Cazzaniga.
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
Silvia Gregori;Daniela Tomasoni;Valentina Pacciani;Miriam Scirpoli.
Tr1 cells: from discovery to their clinical application.
Manuela Battaglia;Silvia Gregori;Rosa Bacchetta;Maria Grazia Roncarolo.
Seminars in Immunology (2006)
Erratum: Interleukin-10- secreting type 1 regulatory T cells in rodents and humans (Immunological Reviews (2006) 212, (28-50))
M. G. Roncarolo;S. Gregori;M. Battaglia;R. Bacchetta.
Immunological Reviews (2006)
CD4+ T-regulatory cells: toward therapy for human diseases.
Sarah E. Allan;Raewyn Broady;Silvia Gregori;Megan E. Himmel.
Immunological Reviews (2008)
Dynamics of Pathogenic and Suppressor T Cells in Autoimmune Diabetes Development
Silvia Gregori;Nadia Giarratana;Simona Smiroldo;Luciano Adorini.
Journal of Immunology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: